| Phase I Oncology

Phase I Oncology

Why Salus

Salus IRB board members are highly experienced in reviewing oncology research, including Phase I. Board members are familiar with oncology research design and protocol development, and board membership includes a radiation safety officer, oncology nurse, and a patient advocate in oncology.

Salus offers:

An experienced, CIP-certified Client Services Manager (CSM) assigned to each project from study start-up to close-out
Competitive review and response times
Rapid study start-up
Streamlined submission process
Immediate notification of board decisions following meetings
Development of site-specific submission forms
Development of site-specific template informed consent documents
Same-day approval for minor modifications to approved research
GlobeSync™ Virtual Workspace allowing 24/7 secure access to the complete IRB study file

For more information, contact Client Services.

855.300.0815